Sort
15,273 grants matching “antimicrobial resistance”
Genomics-Assisted Antibiotic Discovery from Unprecedented Microbes of the Great Salt Lake
$617,648Jaclyn Marie Winter · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Emerging multidrug resistance mechanisms in Campylobacter
$617,308Qijing Zhang · Iowa State University · R56 · FY2018 · AI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$617,199Alehandro Hoberman · University Of Pittsburgh At Pittsburgh · N01 · FY2016 · AI
Task V03: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates
$616,957Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2019 · AI
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
$616,500Saumendra N Sarkar · University Of Maryland Baltimore · R01 · FY2025 · AI
Alternative Approaches for E. faecalis Infections
$615,731Barbara E Murray · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · AI
Transcription Termination and its Regulation in E. coli
$615,459Evgeny Nudler · New York University School Of Medicine · R01 · FY2011 · GM
Assessment of CCL3 Therapy in Diabetic Wound Care
$615,364Sasha H Shafikhani · University Of California At Davis · R01 · FY2025 · DK
Single dose azithromycin to prevent cholera in children
$615,286Jason B Harris · Massachusetts General Hospital · R01 · FY2021 · HD
An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
$615,220Steven Carl George · University Of California At Davis · R01 · FY2023 · EB
Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
$615,176Yvonne L Kapila · University Of California Los Angeles · R01 · FY2023 · CA
Aerosol delivery of combinational therapeutics targeting deadly lung infections
$614,933Qi Zhou · Purdue University · R01 · FY2024 · HL
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$614,842Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2025 · AA
Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa
$614,798Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2022 · AI
Antibiotic dereplication by transcriptome analysis
$614,734Karen E. Nelson · Northeastern University · P01 · FY2017 · AI
MRI Track 1: Acquisition of an X-Ray Diffractometer to Enhance Materials and Biomaterials Research and Education at Arkansas State University
$614,411Robert Fleming · Arkansas State University Main Campus · · FY2024 · ENG
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$614,218Molly A Hughes · University Of Virginia · R01 · FY2024 · AI
Mechanisms of Chromosome Maintenance in Bacteria
$614,113Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
$614,066Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2009 · AI
Lactoferrin and lysozyme to promote nutritional, clinical, and enteric recovery: A factorial placebo-controlled randomized trial among children with diarrhea and malnutrition
$613,886Patricia Pavlinac · University Of Washington · R01 · FY2024 · HD
Environmental regulation of bacterial growth and cell division
$613,697Petra A Levin · Washington University · R35 · FY2023 · GM
Drug resistance enablers and their role in antibiotic treatment failure
$613,605Vaughn Cooper · Broad Institute, Inc. · U19 · FY2023 · AI
Inhibitors of latent M. tuberculosis
$613,591Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2012 · AI
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections
$613,450Danielle M Zerr · Seattle Children'S Hospital · R01 · FY2010 · AI
Rational design of transferrin binding protein-based vaccines to combat gonorrhea
$613,296Cynthia Nau Cornelissen · Virginia Commonwealth University · R01 · FY2018 · AI